1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Depression Treatment Therapy Market Size Growth Rate by Type: 2020 VS 2026 1.2.2 Drugs 1.2.3 Treatment device 1.3 Market by Application 1.3.1 Global Depression Treatment Therapy Market Share by Application: 2020 VS 2026 1.3.2 Seasonal affective disorder (SAD) 1.3.3 Major depression 1.3.4 Dysthymia disorder 1.3.5 Postpartum depression 1.3.6 Atypical depression 1.3.7 Psychotic depression 1.3.8 Bipolar disorder 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Depression Treatment Therapy Market Perspective (2015-2026) 2.2 Global Depression Treatment Therapy Growth Trends by Regions 2.2.1 Depression Treatment Therapy Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Depression Treatment Therapy Historic Market Share by Regions (2015-2020) 2.2.3 Depression Treatment Therapy Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Depression Treatment Therapy Players by Market Size 3.1.1 Global Top Depression Treatment Therapy Players by Revenue (2015-2020) 3.1.2 Global Depression Treatment Therapy Revenue Market Share by Players (2015-2020) 3.2 Global Depression Treatment Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Depression Treatment Therapy Revenue 3.4 Global Depression Treatment Therapy Market Concentration Ratio 3.4.1 Global Depression Treatment Therapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Depression Treatment Therapy Revenue in 2019 3.5 Key Players Depression Treatment Therapy Area Served 3.6 Key Players Depression Treatment Therapy Product Solution and Service 3.7 Date of Enter into Depression Treatment Therapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Depression Treatment Therapy Breakdown Data by Type (2015-2026) 4.1 Global Depression Treatment Therapy Historic Market Size by Type (2015-2020) 4.2 Global Depression Treatment Therapy Forecasted Market Size by Type (2021-2026) 5 Depression Treatment Therapy Breakdown Data by Application (2015-2026) 5.1 Global Depression Treatment Therapy Historic Market Size by Application (2015-2020) 5.2 Global Depression Treatment Therapy Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Depression Treatment Therapy Market Size (2015-2026) 6.2 North America Depression Treatment Therapy Market Size by Type (2015-2020) 6.3 North America Depression Treatment Therapy Market Size by Application (2015-2020) 6.4 North America Depression Treatment Therapy Market Size by Country (2015-2020) 6.4.1 United States 6.4.2 Canada 7 Europe 7.1 Europe Depression Treatment Therapy Market Size (2015-2026) 7.2 Europe Depression Treatment Therapy Market Size by Type (2015-2020) 7.3 Europe Depression Treatment Therapy Market Size by Application (2015-2020) 7.4 Europe Depression Treatment Therapy Market Size by Country (2015-2020) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 7.4.6 Nordic 7.4.7 Rest of Europe 8 China 8.1 China Depression Treatment Therapy Market Size (2015-2026) 8.2 China Depression Treatment Therapy Market Size by Type (2015-2020) 8.3 China Depression Treatment Therapy Market Size by Application (2015-2020) 8.4 China Depression Treatment Therapy Market Size by Region (2015-2020) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 Southeast Asia 8.4.5 India 8.4.6 Australia 8.4.7 Rest of Asia-Pacific 9 Japan 9.1 Japan Depression Treatment Therapy Market Size (2015-2026) 9.2 Japan Depression Treatment Therapy Market Size by Type (2015-2020) 9.3 Japan Depression Treatment Therapy Market Size by Application (2015-2020) 9.4 Japan Depression Treatment Therapy Market Size by Country (2015-2020) 9.4.1 Mexico 9.4.2 Brazil 10 Southeast Asia 10.1 Southeast Asia Depression Treatment Therapy Market Size (2015-2026) 10.2 Southeast Asia Depression Treatment Therapy Market Size by Type (2015-2020) 10.3 Southeast Asia Depression Treatment Therapy Market Size by Application (2015-2020) 10.4 Southeast Asia Depression Treatment Therapy Market Size by Country (2015-2020) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 10.4.4 Rest of Middle East & Africa 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Depression Treatment Therapy Introduction 11.1.4 Pfizer Revenue in Depression Treatment Therapy Business (2015-2020)) 11.1.5 Pfizer Recent Development 11.2 Teva Pharmaceutical 11.2.1 Teva Pharmaceutical Company Details 11.2.2 Teva Pharmaceutical Business Overview 11.2.3 Teva Pharmaceutical Depression Treatment Therapy Introduction 11.2.4 Teva Pharmaceutical Revenue in Depression Treatment Therapy Business (2015-2020) 11.2.5 Teva Pharmaceutical Recent Development 11.3 Johnson and Johnson 11.3.1 Johnson and Johnson Company Details 11.3.2 Johnson and Johnson Business Overview 11.3.3 Johnson and Johnson Depression Treatment Therapy Introduction 11.3.4 Johnson and Johnson Revenue in Depression Treatment Therapy Business (2015-2020) 11.3.5 Johnson and Johnson Recent Development 11.4 Merck 11.4.1 Merck Company Details 11.4.2 Merck Business Overview 11.4.3 Merck Depression Treatment Therapy Introduction 11.4.4 Merck Revenue in Depression Treatment Therapy Business (2015-2020) 11.4.5 Merck Recent Development 11.5 Eli Lily 11.5.1 Eli Lily Company Details 11.5.2 Eli Lily Business Overview 11.5.3 Eli Lily Depression Treatment Therapy Introduction 11.5.4 Eli Lily Revenue in Depression Treatment Therapy Business (2015-2020) 11.5.5 Eli Lily Recent Development 11.6 Novartis 11.6.1 Novartis Company Details 11.6.2 Novartis Business Overview 11.6.3 Novartis Depression Treatment Therapy Introduction 11.6.4 Novartis Revenue in Depression Treatment Therapy Business (2015-2020) 11.6.5 Novartis Recent Development 11.7 Sanofi 11.7.1 Sanofi Company Details 11.7.2 Sanofi Business Overview 11.7.3 Sanofi Depression Treatment Therapy Introduction 11.7.4 Sanofi Revenue in Depression Treatment Therapy Business (2015-2020) 11.7.5 Sanofi Recent Development 11.8 AstraZeneca 11.8.1 AstraZeneca Company Details 11.8.2 AstraZeneca Business Overview 11.8.3 AstraZeneca Depression Treatment Therapy Introduction 11.8.4 AstraZeneca Revenue in Depression Treatment Therapy Business (2015-2020) 11.8.5 AstraZeneca Recent Development 11.9 Allergan 11.9.1 Allergan Company Details 11.9.2 Allergan Business Overview 11.9.3 Allergan Depression Treatment Therapy Introduction 11.9.4 Allergan Revenue in Depression Treatment Therapy Business (2015-2020) 11.9.5 Allergan Recent Development 11.10 Mayo Clinic 11.10.1 Mayo Clinic Company Details 11.10.2 Mayo Clinic Business Overview 11.10.3 Mayo Clinic Depression Treatment Therapy Introduction 11.10.4 Mayo Clinic Revenue in Depression Treatment Therapy Business (2015-2020) 11.10.5 Mayo Clinic Recent Development 11.11 Bristol-Myers Squibb 10.11.1 Bristol-Myers Squibb Company Details 10.11.2 Bristol-Myers Squibb Business Overview 10.11.3 Bristol-Myers Squibb Depression Treatment Therapy Introduction 10.11.4 Bristol-Myers Squibb Revenue in Depression Treatment Therapy Business (2015-2020) 10.11.5 Bristol-Myers Squibb Recent Development 11.12 Takeda 10.12.1 Takeda Company Details 10.12.2 Takeda Business Overview 10.12.3 Takeda Depression Treatment Therapy Introduction 10.12.4 Takeda Revenue in Depression Treatment Therapy Business (2015-2020) 10.12.5 Takeda Recent Development 11.13 Brainsway 10.13.1 Brainsway Company Details 10.13.2 Brainsway Business Overview 10.13.3 Brainsway Depression Treatment Therapy Introduction 10.13.4 Brainsway Revenue in Depression Treatment Therapy Business (2015-2020) 10.13.5 Brainsway Recent Development 11.14 Lundbeck 10.14.1 Lundbeck Company Details 10.14.2 Lundbeck Business Overview 10.14.3 Lundbeck Depression Treatment Therapy Introduction 10.14.4 Lundbeck Revenue in Depression Treatment Therapy Business (2015-2020) 10.14.5 Lundbeck Recent Development 11.15 NeuroStar 10.15.1 NeuroStar Company Details 10.15.2 NeuroStar Business Overview 10.15.3 NeuroStar Depression Treatment Therapy Introduction 10.15.4 NeuroStar Revenue in Depression Treatment Therapy Business (2015-2020) 10.15.5 NeuroStar Recent Development 11.16 Otsuka 10.16.1 Otsuka Company Details 10.16.2 Otsuka Business Overview 10.16.3 Otsuka Depression Treatment Therapy Introduction 10.16.4 Otsuka Revenue in Depression Treatment Therapy Business (2015-2020) 10.16.5 Otsuka Recent Development 11.17 VistaGen Therapeutics 10.17.1 VistaGen Therapeutics Company Details 10.17.2 VistaGen Therapeutics Business Overview 10.17.3 VistaGen Therapeutics Depression Treatment Therapy Introduction 10.17.4 VistaGen Therapeutics Revenue in Depression Treatment Therapy Business (2015-2020) 10.17.5 VistaGen Therapeutics Recent Development 11.18 Silver Oak Health 10.18.1 Silver Oak Health Company Details 10.18.2 Silver Oak Health Business Overview 10.18.3 Silver Oak Health Depression Treatment Therapy Introduction 10.18.4 Silver Oak Health Revenue in Depression Treatment Therapy Business (2015-2020) 10.18.5 Silver Oak Health Recent Development 11.19 NeuroSigma 10.19.1 NeuroSigma Company Details 10.19.2 NeuroSigma Business Overview 10.19.3 NeuroSigma Depression Treatment Therapy Introduction 10.19.4 NeuroSigma Revenue in Depression Treatment Therapy Business (2015-2020) 10.19.5 NeuroSigma Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Depression Treatment Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 3. Key Players of Drugs Table 4. Key Players of Treatment device Table 5. Global Depression Treatment Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 6. Global Depression Treatment Therapy Market Size by Regions (US$ Million): 2020 VS 2026 Table 7. Global Depression Treatment Therapy Market Size by Regions (2015-2020) (US$ Million) Table 8. Global Depression Treatment Therapy Market Share by Regions (2015-2020) Table 9. Global Depression Treatment Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 10. Global Depression Treatment Therapy Market Share by Regions (2021-2026) Table 11. Depression Treatment Therapy Market Market Trends Table 12. Depression Treatment Therapy Market Drivers Table 13. Depression Treatment Therapy Market Challenges Table 14. Depression Treatment Therapy Market Restraints Table 15. Global Depression Treatment Therapy Revenue by Players (2015-2020) (US$ Million) Table 16. Global Depression Treatment Therapy Market Share by Players (2015-2020) Table 17. Global Top Depression Treatment Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Depression Treatment Therapy as of 2019) Table 18. Global Depression Treatment Therapy by Players Market Concentration Ratio (CR5 and HHI) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Depression Treatment Therapy Product Solution and Service Table 21. Mergers & Acquisitions, Expansion Plans Table 22. Global Depression Treatment Therapy Market Size by Type (2015-2020) (US$ Million) Table 23. Global Depression Treatment Therapy Market Size Share by Type (2015-2020) Table 24. Global Depression Treatment Therapy Revenue Market Share by Type (2021-2026) Table 25. Global Depression Treatment Therapy Market Size Share by Application (2015-2020) Table 26. Global Depression Treatment Therapy Market Size by Application (2015-2020) (US$ Million) Table 27. Global Depression Treatment Therapy Market Size Share by Application (2021-2026) Table 28. North America Depression Treatment Therapy Market Size by Type (2015-2020) (US$ Million) Table 29. North America Depression Treatment Therapy Market Share by Type (2015-2020) Table 30. North America Depression Treatment Therapy Market Size by Application (2015-2020) (US$ Million) Table 31. North America Depression Treatment Therapy Market Share by Application (2015-2020) Table 32. North America Depression Treatment Therapy Market Size by Country (US$ Million) (2015-2020) Table 33. North America Depression Treatment Therapy Market Share by Country (2015-2020) Table 34. Europe Depression Treatment Therapy Market Size by Type (2015-2020) (US$ Million) Table 35. Europe Depression Treatment Therapy Market Share by Type (2015-2020) Table 36. Europe Depression Treatment Therapy Market Size by Application (2015-2020) (US$ Million) Table 37. Europe Depression Treatment Therapy Market Share by Application (2015-2020) Table 38. Europe Depression Treatment Therapy Market Size by Country (US$ Million) (2015-2020) Table 39. Europe Depression Treatment Therapy Market Share by Country (2015-2020) Table 40. China Depression Treatment Therapy Market Size by Type (2015-2020) (US$ Million) Table 41. China Depression Treatment Therapy Market Share by Type (2015-2020) Table 42. China Depression Treatment Therapy Market Size by Application (2015-2020) (US$ Million) Table 43. China Depression Treatment Therapy Market Share by Application (2015-2020) Table 44. China Depression Treatment Therapy Market Size by Region (US$ Million) (2015-2020) Table 45. China Depression Treatment Therapy Market Share by Region (2015-2020) Table 46. Japan Depression Treatment Therapy Market Size by Type (2015-2020) (US$ Million) Table 47. Japan Depression Treatment Therapy Market Share by Type (2015-2020) Table 48. Japan Depression Treatment Therapy Market Size by Application (2015-2020) (US$ Million) Table 49. Japan Depression Treatment Therapy Market Share by Application (2015-2020) Table 50. Japan Depression Treatment Therapy Market Size by Country (US$ Million) (2015-2020) Table 51. Japan Depression Treatment Therapy Market Share by Country (2015-2020) Table 52. Southeast Asia Depression Treatment Therapy Market Size by Type (2015-2020) (US$ Million) Table 53. Southeast Asia Depression Treatment Therapy Market Share by Type (2015-2020) Table 54. Southeast Asia Depression Treatment Therapy Market Size by Application (2015-2020) (US$ Million) Table 55. Southeast Asia Depression Treatment Therapy Market Share by Application (2015-2020) Table 56. Southeast Asia Depression Treatment Therapy Market Size by Country (US$ Million) (2015-2020) Table 57. Southeast Asia Depression Treatment Therapy Market Share by Country (2015-2020) Table 58. Pfizer Company Details Table 59. Pfizer Business Overview Table 60. Pfizer Product Table 61. Pfizer Revenue in Depression Treatment Therapy Business (2015-2020) (US$ Million) Table 62. Pfizer Recent Development Table 63. Teva Pharmaceutical Company Details Table 64. Teva Pharmaceutical Business Overview Table 65. Teva Pharmaceutical Product Table 66. Teva Pharmaceutical Revenue in Depression Treatment Therapy Business (2015-2020) (US$ Million) Table 67. Teva Pharmaceutical Recent Development Table 68. Johnson and Johnson Company Details Table 69. Johnson and Johnson Business Overview Table 70. Johnson and Johnson Product Table 71. Johnson and Johnson Revenue in Depression Treatment Therapy Business (2015-2020) (US$ Million) Table 72. Johnson and Johnson Recent Development Table 73. Merck Company Details Table 74. Merck Business Overview Table 75. Merck Product Table 76. Merck Revenue in Depression Treatment Therapy Business (2015-2020) (US$ Million) Table 77. Merck Recent Development Table 78. Eli Lily Company Details Table 79. Eli Lily Business Overview Table 80. Eli Lily Product Table 81. Eli Lily Revenue in Depression Treatment Therapy Business (2015-2020) (US$ Million) Table 82. Eli Lily Recent Development Table 83. Novartis Company Details Table 84. Novartis Business Overview Table 85. Novartis Product Table 86. Novartis Revenue in Depression Treatment Therapy Business (2015-2020) (US$ Million) Table 87. Novartis Recent Development Table 88. Sanofi Company Details Table 89. Sanofi Business Overview Table 90. Sanofi Product Table 91. Sanofi Revenue in Depression Treatment Therapy Business (2015-2020) (US$ Million) Table 92. Sanofi Recent Development Table 93. AstraZeneca Business Overview Table 94. AstraZeneca Product Table 95. AstraZeneca Company Details Table 96. AstraZeneca Revenue in Depression Treatment Therapy Business (2015-2020) (US$ Million) Table 97. AstraZeneca Recent Development Table 98. Allergan Company Details Table 99. Allergan Business Overview Table 100. Allergan Product Table 101. Allergan Revenue in Depression Treatment Therapy Business (2015-2020) (US$ Million) Table 102. Allergan Recent Development Table 103. Mayo Clinic Company Details Table 104. Mayo Clinic Business Overview Table 105. Mayo Clinic Product Table 106. Mayo Clinic Revenue in Depression Treatment Therapy Business (2015-2020) (US$ Million) Table 107. Mayo Clinic Recent Development Table 108. Bristol-Myers Squibb Company Details Table 109. Bristol-Myers Squibb Business Overview Table 110. Bristol-Myers Squibb Product Table 111. Bristol-Myers Squibb Revenue in Depression Treatment Therapy Business (2015-2020) (US$ Million) Table 112. Bristol-Myers Squibb Recent Development Table 113. Takeda Company Details Table 114. Takeda Business Overview Table 115. Takeda Product Table 116. Takeda Revenue in Depression Treatment Therapy Business (2015-2020) (US$ Million) Table 117. Takeda Recent Development Table 118. Brainsway Company Details Table 119. Brainsway Business Overview Table 120. Brainsway Product Table 121. Brainsway Revenue in Depression Treatment Therapy Business (2015-2020) (US$ Million) Table 122. Brainsway Recent Development Table 123. Lundbeck Company Details Table 124. Lundbeck Business Overview Table 125. Lundbeck Product Table 126. Lundbeck Revenue in Depression Treatment Therapy Business (2015-2020) (US$ Million) Table 127. Lundbeck Recent Development Table 128. NeuroStar Company Details Table 129. NeuroStar Business Overview Table 130. NeuroStar Product Table 131. NeuroStar Revenue in Depression Treatment Therapy Business (2015-2020) (US$ Million) Table 132. NeuroStar Recent Development Table 133. Otsuka Company Details Table 134. Otsuka Business Overview Table 135. Otsuka Product Table 136. Otsuka Revenue in Depression Treatment Therapy Business (2015-2020) (US$ Million) Table 137. Otsuka Recent Development Table 138. VistaGen Therapeutics Company Details Table 139. VistaGen Therapeutics Business Overview Table 140. VistaGen Therapeutics Product Table 141. VistaGen Therapeutics Revenue in Depression Treatment Therapy Business (2015-2020) (US$ Million) Table 142. VistaGen Therapeutics Recent Development Table 143. Silver Oak Health Company Details Table 144. Silver Oak Health Business Overview Table 145. Silver Oak Health Product Table 146. Silver Oak Health Revenue in Depression Treatment Therapy Business (2015-2020) (US$ Million) Table 147. Silver Oak Health Recent Development Table 148. NeuroSigma Company Details Table 149. NeuroSigma Business Overview Table 150. NeuroSigma Product Table 151. NeuroSigma Revenue in Depression Treatment Therapy Business (2015-2020) (US$ Million) Table 152. NeuroSigma Recent Development Table 153. Research Programs/Design for This Report Table 154. Key Data Information from Secondary Sources Table 155. Key Data Information from Primary Sources List of Figures Figure 1. Global Depression Treatment Therapy Market Share by Type: 2020 VS 2026 Figure 2. Drugs Features Figure 3. Treatment device Features Figure 4. Global Depression Treatment Therapy Market Share by Application: 2020 VS 2026 Figure 5. Seasonal affective disorder (SAD) Case Studies Figure 6. Major depression Case Studies Figure 7. Dysthymia disorder Case Studies Figure 8. Postpartum depression Case Studies Figure 9. Atypical depression Case Studies Figure 10. Psychotic depression Case Studies Figure 11. Bipolar disorder Case Studies Figure 12. Depression Treatment Therapy Report Years Considered Figure 13. Global Depression Treatment Therapy Market Size (US$ Million), YoY Growth 2015-2026 Figure 14. Global Depression Treatment Therapy Market Share by Regions: 2020 VS 2026 Figure 15. Global Depression Treatment Therapy Market Share by Regions (2021-2026) Figure 16. Global Depression Treatment Therapy Market Share by Players in 2019 Figure 17. Global Top Depression Treatment Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Depression Treatment Therapy as of 2019 Figure 18. The Top 10 and 5 Players Market Share by Depression Treatment Therapy Revenue in 2019 Figure 19. North America Depression Treatment Therapy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 20. United States Depression Treatment Therapy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. Canada Depression Treatment Therapy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. Europe Depression Treatment Therapy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. Germany Depression Treatment Therapy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. France Depression Treatment Therapy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. U.K. Depression Treatment Therapy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Italy Depression Treatment Therapy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Russia Depression Treatment Therapy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. Nordic Depression Treatment Therapy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. Rest of Europe Depression Treatment Therapy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. Asia-Pacific Depression Treatment Therapy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. China Depression Treatment Therapy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. Japan Depression Treatment Therapy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. South Korea Depression Treatment Therapy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Southeast Asia Depression Treatment Therapy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. India Depression Treatment Therapy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Australia Depression Treatment Therapy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Rest of Asia-Pacific Depression Treatment Therapy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Latin America Depression Treatment Therapy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Mexico Depression Treatment Therapy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Brazil Depression Treatment Therapy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. Middle East & Africa Depression Treatment Therapy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Turkey Depression Treatment Therapy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 43. Saudi Arabia Depression Treatment Therapy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 44. UAE Depression Treatment Therapy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 45. Rest of Middle East & Africa Depression Treatment Therapy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 46. Pfizer Revenue Growth Rate in Depression Treatment Therapy Business (2015-2020) Figure 47. Teva Pharmaceutical Revenue Growth Rate in Depression Treatment Therapy Business (2015-2020) Figure 48. Johnson and Johnson Revenue Growth Rate in Depression Treatment Therapy Business (2015-2020) Figure 49. Merck Revenue Growth Rate in Depression Treatment Therapy Business (2015-2020) Figure 50. Eli Lily Revenue Growth Rate in Depression Treatment Therapy Business (2015-2020) Figure 51. Novartis Revenue Growth Rate in Depression Treatment Therapy Business (2015-2020) Figure 52. Sanofi Revenue Growth Rate in Depression Treatment Therapy Business (2015-2020) Figure 53. AstraZeneca Revenue Growth Rate in Depression Treatment Therapy Business (2015-2020) Figure 54. Allergan Revenue Growth Rate in Depression Treatment Therapy Business (2015-2020) Figure 55. Mayo Clinic Revenue Growth Rate in Depression Treatment Therapy Business (2015-2020) Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Depression Treatment Therapy Business (2015-2020) Figure 57. Takeda Revenue Growth Rate in Depression Treatment Therapy Business (2015-2020) Figure 58. Brainsway Revenue Growth Rate in Depression Treatment Therapy Business (2015-2020) Figure 59. Lundbeck Revenue Growth Rate in Depression Treatment Therapy Business (2015-2020) Figure 60. NeuroStar Revenue Growth Rate in Depression Treatment Therapy Business (2015-2020) Figure 61. Otsuka Revenue Growth Rate in Depression Treatment Therapy Business (2015-2020) Figure 62. VistaGen Therapeutics Revenue Growth Rate in Depression Treatment Therapy Business (2015-2020) Figure 63. Silver Oak Health Revenue Growth Rate in Depression Treatment Therapy Business (2015-2020) Figure 64. NeuroSigma Revenue Growth Rate in Depression Treatment Therapy Business (2015-2020) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

Pfizer Teva Pharmaceutical Johnson and Johnson Merck Eli Lily Novartis Sanofi AstraZeneca Allergan Mayo Clinic Bristol-Myers Squibb Takeda Brainsway Lundbeck NeuroStar Otsuka VistaGen Therapeutics Silver Oak Health NeuroSigma